However, mice treated with the STING agonist 2′3′-cyclic-GMP-AMP (cGAMP) have improved metabolic performance [21], challenging the canonical view on STING function in obesity. The gene discussed is STING1; the disease is obesity due to melanocortin 4 receptor deficiency.